I. E. Smith

Basal-like breast carcinomas: clinical outcome and response to chemotherapy

Susana Banerjee, Jorge S. Reis‐Filho, S. Ashley et al. · Journal of Clinical Pathology · 2006 · 294 citations · Full text

Medicine, Oncology, Pathology +16

HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancer.

Mitch Dowsett, Catherine Harper‐Wynne, Irene Boeddinghaus et al. · PubMed · 2001 · 173 citations

Medicine, Endocrinology, Oncology +14

Endocrine Therapy, New Biologicals, and New Study Designs for Presurgical Studies in Breast Cancer

Mitch Dowsett, I. E. Smith, John Robertson et al. · JNCI Monographs · 2011 · 86 citations · Full text

Medicine, Endocrinology, Oncology +17

High dose carboplatin in the treatment of lung cancer and mesotherlioma: a phase I dose escalation study

Martin Gore, A. Hilary Calvert, I. E. Smith · European Journal of Cancer and Clinical Oncology · 1987 · 71 citations

Medicine, Oncology, Pharmacology +15

VP 16-213 in acute myelogenous leukaemia

I. E. Smith, Hugh M. Clink, Michael Gerken et al. · Postgraduate Medical Journal · 1976 · 55 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10